From US$ 10.99 Billion to US$ 16.81 Billion: The Growth Story of the CNS Stimulant Drugs Market
Central nervous system stimulant drugs are increasingly important in the management of conditions associated with impaired attention, excessive daytime sleepiness, fatigue, and certain neurological and behavioral disorders. These therapies act primarily by increasing the activity of neurotransmitters in the brain, supporting improved alertness, concentration, wakefulness, and cognitive...
0 Комментарии 0 Поделились 76 Просмотры 0 предпросмотр
Спонсоры